A detailed history of Quantum Private Wealth, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Quantum Private Wealth, LLC holds 62,274 shares of EXAS stock, worth $3.29 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares
62,274
Previous 62,974 1.11%
Holding current value
$3.29 Million
Previous $2.66 Million 59.4%
% of portfolio
1.5%
Previous 0.98%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$42.43 - $70.83 $29,701 - $49,581
-700 Reduced 1.11%
62,274 $4.24 Million
Q2 2024

Jul 17, 2024

BUY
$41.33 - $74.26 $120,063 - $215,725
2,905 Added 4.84%
62,974 $2.66 Million
Q1 2024

May 07, 2024

BUY
$56.27 - $73.77 $73,432 - $96,269
1,305 Added 2.22%
60,069 $4.15 Million
Q4 2023

Jan 30, 2024

BUY
$59.06 - $75.72 $23,624 - $30,288
400 Added 0.69%
58,764 $4.35 Million
Q3 2023

Nov 02, 2023

BUY
$65.94 - $99.04 $3,297 - $4,952
50 Added 0.09%
58,364 $3.98 Million
Q2 2023

Jul 27, 2023

BUY
$62.68 - $95.05 $12,285 - $18,629
196 Added 0.34%
58,314 $5.48 Million
Q1 2023

Apr 19, 2023

SELL
$47.19 - $70.77 $2,123 - $3,184
-45 Reduced 0.08%
58,118 $3.94 Million
Q4 2022

Jan 20, 2023

SELL
$30.35 - $53.15 $42,884 - $75,100
-1,413 Reduced 2.37%
58,163 $0
Q3 2022

Nov 01, 2022

SELL
$31.97 - $49.37 $26,375 - $40,730
-825 Reduced 1.37%
59,576 $1.94 Million
Q2 2022

Aug 17, 2022

SELL
$35.61 - $76.23 $30,161 - $64,566
-847 Reduced 1.38%
60,401 $2.38 Million
Q1 2022

May 27, 2022

BUY
$57.56 - $82.54 $12,951 - $18,571
225 Added 0.37%
61,248 $4.28 Million
Q4 2021

May 26, 2022

BUY
$72.5 - $100.68 $4.42 Million - $6.14 Million
61,023 New
61,023 $4.75 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Quantum Private Wealth, LLC Portfolio

Follow Quantum Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantum Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantum Private Wealth, LLC with notifications on news.